메뉴 건너뛰기




Volumn , Issue , 2012, Pages

A rare but severe pulmonary side effect of cetuximab in two patients

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CARBOPLATIN; CEFEPIME; CEFTRIAXONE; CETUXIMAB; CISPLATIN; COTRIMOXAZOLE; DOCETAXEL; ERTAPENEM; FLUOROURACIL; PACLITAXEL; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; PROTON PUMP INHIBITOR;

EID: 84865518140     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-03-2012-5973     Document Type: Article
Times cited : (16)

References (8)
  • 1
    • 16244400108 scopus 로고    scopus 로고
    • Cetuximab: An epidermal growth factor receptor chimeric human-murine monoclonal antibody
    • DOI 10.1358/dot.2005.41.2.882662
    • Harding J, Burtness B. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody. Drugs Today (Barc) 2005;41:107-27. (Pubitemid 40461533)
    • (2005) Drugs of Today , vol.41 , Issue.2 , pp. 107-127
    • Harding, J.1    Burtness, B.2
  • 2
    • 36348987149 scopus 로고    scopus 로고
    • Cetuximab: A review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer
    • Blick SK, Scott LJ. Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer. Drugs 2007;67:2585-607. (Pubitemid 350159168)
    • (2007) Drugs , vol.67 , Issue.17 , pp. 2585-2607
    • Blick, S.K.A.1    Scott, L.J.2
  • 4
    • 69549138343 scopus 로고    scopus 로고
    • Association of cetuximab with adverse pulmonary events in cancer patients: A comprehensive review
    • Hoag JB, Azizi A, Doherty TJ, et al. Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review. J Exp Clin Cancer Res 2009;28:113.
    • (2009) J Exp Clin Cancer Res , vol.28 , pp. 113
    • Hoag, J.B.1    Azizi, A.2    Doherty, T.J.3
  • 5
    • 84865520599 scopus 로고    scopus 로고
    • Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies
    • Burudpakdee C, Zhao Z, Munakata J, et al. Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies. J Med Econ 2011;106:443-50.
    • (2011) J Med Econ , vol.106 , pp. 443-450
    • Burudpakdee, C.1    Zhao, Z.2    Munakata, J.3
  • 6
    • 84865523815 scopus 로고    scopus 로고
    • Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients
    • Kang HJ, Park JS, Kim DW, et al. Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients. Respir Med 2011;15:371-7.
    • (2011) Respir Med , vol.15 , pp. 371-377
    • Kang, H.J.1    Park, J.S.2    Kim, D.W.3
  • 7
    • 79953216429 scopus 로고    scopus 로고
    • Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan
    • Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011;364:1126-33.
    • (2011) N Engl J Med , vol.364 , pp. 1126-1133
    • Chen, P.1    Lin, J.J.2    Lu, C.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.